Arcutis Biotherapeutics Inc. (ARQT)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
28. 49
+0.75
+2.7037%
$
3.35B Market Cap
- P/E Ratio
- Div Yield
1.27M Volume
-3.88 Eps
$ 27.74
Previous Close 
Want to track ARQT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arcutis Biotherapeutics Inc. (ARQT) Statistics
Valuation metrics
Market Cap 3.35B
Enterprise value 3.64B
Trailing P/E (ttm) -1,483.85
Forward P/E -
PEG ratio -3.03
Price/Sales (ttm) 8.57
Price/Book (mrq) 19.43
Enterprise Value/Revenue 8.77
Enterprise Value/EBITDA 242.45
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.38M
Average volume (90 days) 1.77M
Price summary
52-Week low 13.7
52-Week high 31.77
Beta -
50-Day moving average 26.01
200-Day moving average 24.66
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.01%
Operating margin 0.01%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.21
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.73
Total debt (mrq) -
Total Debt/Equity (mrq) 0.6
Current ratio (mrq) 2.68%
Book value per share (mrq) 1.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
